Skip to main content

Table 4 The pooled prevalence of different genotypes of HPV among HIV-infected women in LMICs

From: Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

HPV genotypes

Random effects pooled %ES (95% CI)

No of studies

χ2

DF

p value

I2 (%)

16

20 (12.0–28-0)

13

814.56

12

< 0.001

98.53

18

15 (10.0–20.0)

12

390.48

11

< 0.001

97.18

26

4 (2.0–5.0)

3

2.12

2

0.35

5.68

31

11 (7.0–14.0)

11

260.91

10

< 0.001

96.17

33

8 (5.0–11.0)

8

72.55

7

< 0.001

90.35

35

10 (6.0–14.0)

9

120.78

8

< 0.001

93.38

39

5 (3.0–8.0)

7

53.68

6

< 0.001

88.82

45

7 (5.0–10.0)

10

114.13

9

< 0.001

92.11

51

8 (5.0–10.0)

9

37.74

8

< 0.001

78.80

52

13 (9.0–18.0)

9

157.30

8

< 0.001

94.91

53

10 (5.0–16.0)

7

83.80

6

< 0.001

92.84

56

6 (4.0–9.0)

7

45.42

6

< 0.001

86.79

58

11 (8.0–14.0)

11

94.54

10

< 0.001

89.42

59

5 (3.0–7.0)

7

66.49

6

< 0.001

90.98

66

8 (3.0–12.0)

5

44.36

4

< 0.001

90.98

67

2 (1.0–3.0)

2

 

1

  

68

6 (3.0–10.0)

6

74.28

5

< 0.001

93.27

69

4 (2.0–5.0)

2

 

1

  

70

 

1

    

73

5 (2.0–8.0)

4

12.73

3

0.01

76.42

82

5 (3.0–6.0)

4

3.54

3

0.32

15.21

  1. HPV, human papillomavirus; χ2, heterogeinity chi-square; DF, degree of freedom; I2, heterogeneity; ES, effect size, CI, confidence interval
Back to article page

Virology Journal

ISSN: 1743-422X